ID   TRXR1_HUMAN             Reviewed;         649 AA.
AC   Q16881; B7Z1F4; B7Z3Y8; B7Z904; E9PMY9; F5H780; Q6FI31; Q6VB40;
AC   Q6VB41; Q6VB42; Q6VBP2; Q6VBP3; Q6VBP4; Q6VBP5; Q6VBP9; Q6VBQ0;
AC   Q6YNQ1; Q76P53; Q7LA96; Q8WVC8; Q99475; Q9UES8; Q9UH79;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   26-FEB-2008, sequence version 3.
DT   10-MAY-2017, entry version 197.
DE   RecName: Full=Thioredoxin reductase 1, cytoplasmic;
DE            Short=TR;
DE            EC=1.8.1.9;
DE   AltName: Full=Gene associated with retinoic and interferon-induced mortality 12 protein;
DE            Short=GRIM-12;
DE            Short=Gene associated with retinoic and IFN-induced mortality 12 protein;
DE   AltName: Full=KM-102-derived reductase-like factor;
DE   AltName: Full=Thioredoxin reductase TR1;
GN   Name=TXNRD1; Synonyms=GRIM12, KDRF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), PROTEIN SEQUENCE OF 153-161;
RP   307-315 AND 585-607, AND VARIANT GLY-365.
RC   TISSUE=Placenta;
RX   PubMed=7589432; DOI=10.1016/0014-5793(95)01003-W;
RA   Gasdaska P.Y., Gasdaska J.R., Cochran S., Powis G.;
RT   "Cloning and sequencing of a human thioredoxin reductase.";
RL   FEBS Lett. 373:5-9(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), PROTEIN SEQUENCE OF 122-127
RP   AND 147-151, AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow stroma;
RX   PubMed=8999974; DOI=10.1074/jbc.272.4.2570;
RA   Koishi R., Kawashima I., Yoshimura C., Sugawara M., Serizawa N.;
RT   "Cloning and characterization of a novel oxidoreductase KDRF from a
RT   human bone marrow-derived stromal cell line KM-102.";
RL   J. Biol. Chem. 272:2570-2577(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), FUNCTION, AND INDUCTION.
RC   TISSUE=Mammary carcinoma;
RX   PubMed=9774665; DOI=10.1128/MCB.18.11.6493;
RA   Hofman E.R., Boyanapalli M., Lindner D.J., Weihua X., Hassel B.A.,
RA   Jagus R., Gutierrez P.L., Kalvakolanu D.V.;
RT   "Thioredoxin reductase mediates cell death effects of the combination
RT   of beta interferon and retinoic acid.";
RL   Mol. Cell. Biol. 18:6493-6504(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL NUCLEOTIDE SEQUENCE
RP   [MRNA] (ISOFORMS 2; 3; 4 AND 5), AND VARIANT GLY-365.
RC   TISSUE=Mammary gland, Ovary, Testis, and Thymus;
RX   PubMed=14980707; DOI=10.1016/j.freeradbiomed.2003.12.004;
RA   Rundloef A.-K., Janard M., Miranda-Vizuete A., Arner E.S.;
RT   "Evidence for intriguingly complex transcription of human thioredoxin
RT   reductase 1.";
RL   Free Radic. Biol. Med. 36:641-656(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RA   Schuetze N., Bachthaler M., Lechner A., Koehrle J., Jakob F.;
RT   "Identification by ddPCR of thioredoxin reductase as a vitamin D
RT   regulated gene in human osteoblasts.";
RL   Submitted (AUG-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RA   Xu L., Dai R., Xu J.Y.;
RT   "Cloning and sequencing of thioredoxin reductase gene from human
RT   brain.";
RL   Submitted (NOV-1999) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 7).
RC   TISSUE=Astrocyte, Thalamus, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S.,
RA   Neubert P., Kstrang K., Schatten R., Shen B., Henze S., Mar W.,
RA   Korn B., Zuo D., Hu Y., LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RG   NIEHS SNPs program;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M.,
RA   Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Montgomery K.T., Morgan M.B.,
RA   Nazareth L.V., Scott G., Sodergren E., Song X.-Z., Steffen D.,
RA   Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y., Zhang Z.,
RA   Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G., Chen Z.,
RA   Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H., Draper H.,
RA   Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S., Kelly S.H.,
RA   Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V.,
RA   Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.H., Santibanez J.,
RA   Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q., Williams G.A.,
RA   Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V., Bailey M.,
RA   Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E., Burkett C.E.,
RA   Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M.,
RA   Dathorne S.R., David R., Davis C.M., Davy-Carroll L., Deshazo D.R.,
RA   Donlin J.E., D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J.,
RA   Escotto M., Flagg N., Forbes L.D., Gabisi A.M., Garza M., Hamilton C.,
RA   Henderson N., Hernandez O., Hines S., Hogues M.E., Huang M.,
RA   Idlebird D.G., Johnson R., Jolivet A., Jones S., Kagan R., King L.M.,
RA   Leal B., Lebow H., Lee S., LeVan J.M., Lewis L.C., London P.,
RA   Lorensuhewa L.M., Loulseged H., Lovett D.A., Lucier A., Lucier R.L.,
RA   Ma J., Madu R.C., Mapua P., Martindale A.D., Martinez E., Massey E.,
RA   Mawhiney S., Meador M.G., Mendez S., Mercado C., Mercado I.C.,
RA   Merritt C.E., Miner Z.L., Minja E., Mitchell T., Mohabbat F.,
RA   Mohabbat K., Montgomery B., Moore N., Morris S., Munidasa M.,
RA   Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O., Nwokenkwo S.,
RA   Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.-L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D.,
RA   Trejos Z.Y., Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I.,
RA   Vera V.A., Villasana D.M., Wang L., Ward-Moore S., Warren J.T.,
RA   Wei X., White F., Williamson A.L., Wleczyk R., Wooden H.S.,
RA   Wooden S.H., Yen J., Yoon L., Yoon V., Zorrilla S.E., Nelson D.,
RA   Kucherlapati R., Weinstock G., Gibbs R.A.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND IDENTIFICATION.
RC   TISSUE=Trachea;
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [14]
RP   PROTEIN SEQUENCE OF 307-316; 449-456; 466-476 AND 638-649, BLOCKAGE OF
RP   N-TERMINUS, SELENOCYSTEINE AT SEC-648, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=8650234; DOI=10.1073/pnas.93.12.6146;
RA   Gladyshev V.N., Jeang K.-T., Stadtman T.C.;
RT   "Selenocysteine, identified as the penultimate C-terminal residue in
RT   human T-cell thioredoxin reductase, corresponds to TGA in the human
RT   placental gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:6146-6151(1996).
RN   [15]
RP   FUNCTION, HOMODIMERIZATION, CHARACTERIZATION, AND PRESENCE OF
RP   SELENOCYSTEINE.
RX   PubMed=8577704; DOI=10.1073/pnas.93.3.1006;
RA   Tamura T., Stadtman T.C.;
RT   "A new selenoprotein from human lung adenocarcinoma cells:
RT   purification, properties, and thioredoxin reductase activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:1006-1011(1996).
RN   [16]
RP   ALTERNATIVE SPLICING (ISOFORMS 1; 2; 3; 4; 5 AND 6), AND DOMAIN.
RX   PubMed=15379556; DOI=10.1021/bi048478t;
RA   Su D., Gladyshev V.N.;
RT   "Alternative splicing involving the thioredoxin reductase module in
RT   mammals: a glutaredoxin-containing thioredoxin reductase 1.";
RL   Biochemistry 43:12177-12188(2004).
RN   [17]
RP   FUNCTION, INTERACTION WITH ESR1 AND ESR2, SUBCELLULAR LOCATION, AND
RP   TISSUE SPECIFICITY (ISOFORM 4).
RX   PubMed=15199063; DOI=10.1074/jbc.M402753200;
RA   Damdimopoulos A.E., Miranda-Vizuete A., Treuter E., Gustafsson J.-A.,
RA   Spyrou G.;
RT   "An alternative splicing variant of the selenoprotein thioredoxin
RT   reductase is a modulator of estrogen signaling.";
RL   J. Biol. Chem. 279:38721-38729(2004).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-281, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer
RT   cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [19]
RP   INTERACTION WITH HERC5, AND ISGYLATION.
RX   PubMed=16815975; DOI=10.1073/pnas.0600397103;
RA   Wong J.J., Pung Y.F., Sze N.S., Chin K.C.;
RT   "HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates
RT   type I IFN-induced ISGylation of protein targets.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:10735-10740(2006).
RN   [20]
RP   FUNCTION, TISSUE SPECIFICITY, AND INDUCTION (ISOFORM 1).
RX   PubMed=18042542; DOI=10.1074/jbc.M708939200;
RA   Dammeyer P., Damdimopoulos A.E., Nordman T., Jimenez A.,
RA   Miranda-Vizuete A., Arner E.S.J.;
RT   "Induction of cell membrane protrusions by the N-terminal glutaredoxin
RT   domain of a rare splice variant of human thioredoxin reductase 1.";
RL   J. Biol. Chem. 283:2814-2821(2008).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 5), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1 (ISOFORM 5), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) (ISOFORM 5).
RX   PubMed=17512005; DOI=10.1016/j.jmb.2007.04.044;
RA   Fritz-Wolf K., Urig S., Becker K.;
RT   "The structure of human thioredoxin reductase 1 provides insights into
RT   C-terminal rearrangements during catalysis.";
RL   J. Mol. Biol. 370:116-127(2007).
CC   -!- FUNCTION: Isoform 1 may possess glutaredoxin activity as well as
CC       thioredoxin reductase activity and induces actin and tubulin
CC       polymerization, leading to formation of cell membrane protrusions.
CC       Isoform 4 enhances the transcriptional activity of estrogen
CC       receptors alpha and beta while isoform 5 enhances the
CC       transcriptional activity of the beta receptor only. Isoform 5 also
CC       mediates cell death induced by a combination of interferon-beta
CC       and retinoic acid. {ECO:0000269|PubMed:15199063,
CC       ECO:0000269|PubMed:18042542, ECO:0000269|PubMed:8577704,
CC       ECO:0000269|PubMed:9774665}.
CC   -!- CATALYTIC ACTIVITY: Thioredoxin + NADP(+) = thioredoxin disulfide
CC       + NADPH.
CC   -!- COFACTOR:
CC       Name=FAD; Xref=ChEBI:CHEBI:57692;
CC       Note=Binds 1 FAD per subunit.;
CC   -!- SUBUNIT: Homodimer. Isoform 4 interacts with ESR1 and ESR2.
CC       Interacts with HERC5. {ECO:0000269|PubMed:15199063,
CC       ECO:0000269|PubMed:16815975}.
CC   -!- INTERACTION:
CC       Q03135:CAV1; NbExp=4; IntAct=EBI-716617, EBI-603614;
CC       P03372:ESR1; NbExp=4; IntAct=EBI-9080335, EBI-78473;
CC       Q92731:ESR2; NbExp=3; IntAct=EBI-9080335, EBI-78505;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Isoform 4: Cytoplasm. Nucleus.
CC   -!- SUBCELLULAR LOCATION: Isoform 5: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC       Name=1; Synonyms=V, TXNRD1_v3;
CC         IsoId=Q16881-1; Sequence=Displayed;
CC         Note=Minor isoform.;
CC       Name=2; Synonyms=II, TXNRD1_v4;
CC         IsoId=Q16881-2; Sequence=VSP_031560, VSP_031565;
CC       Name=3; Synonyms=III, TXNRD1_v5;
CC         IsoId=Q16881-3; Sequence=VSP_031562, VSP_031563;
CC       Name=4; Synonyms=IV, TXNRD1_v2, TrxR1b;
CC         IsoId=Q16881-4; Sequence=VSP_031561, VSP_031564;
CC       Name=5; Synonyms=I, TXNRD1_v1, TrxR1a;
CC         IsoId=Q16881-5; Sequence=VSP_031558;
CC         Note=Major isoform. The N-terminus of the sequence is processed
CC         into a mature form that lacks residues Met-151 and Asn-152 at
CC         the N-terminus. Contains a N-acetylmethionine at position 1.
CC         {ECO:0000244|PubMed:19413330, ECO:0000244|PubMed:22223895};
CC       Name=6; Synonyms=VI;
CC         IsoId=Q16881-6; Sequence=VSP_031559;
CC       Name=7;
CC         IsoId=Q16881-7; Sequence=VSP_053819;
CC         Note=No experimental confirmation.;
CC   -!- TISSUE SPECIFICITY: Isoform 1 is expressed predominantly in Leydig
CC       cells (at protein level). Also expressed in ovary, spleen, heart,
CC       liver, kidney and pancreas and in a number of cancer cell lines.
CC       Isoform 4 is widely expressed with highest levels in kidney,
CC       testis, uterus, ovary, prostate, placenta and fetal liver.
CC       {ECO:0000269|PubMed:18042542, ECO:0000269|PubMed:8999974}.
CC   -!- INDUCTION: Isoform 5 is induced by a combination of interferon-
CC       beta and retinoic acid (at protein level). Isoform 1 is induced by
CC       estradiol or testosterone in HeLa cells.
CC       {ECO:0000269|PubMed:9774665}.
CC   -!- DOMAIN: The N-terminal glutaredoxin domain found in isoform 1 does
CC       not contain the C-P-Y-C redox-active motif normally found in
CC       glutaredoxins and has been found to be inactive in classical
CC       glutaredoxin assays. {ECO:0000269|PubMed:15379556}.
CC   -!- PTM: The N-terminus of isoform 5 is blocked.
CC   -!- PTM: ISGylated. {ECO:0000305|PubMed:16815975}.
CC   -!- MISCELLANEOUS: The thioredoxin reductase active site is a redox-
CC       active disulfide bond. The selenocysteine residue is also
CC       essential for catalytic activity.
CC   -!- SIMILARITY: Belongs to the class-I pyridine nucleotide-disulfide
CC       oxidoreductase family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAB35418.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=AAC69621.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=AAF15900.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=AAV38446.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=AAZ67916.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=BAA13674.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=BAH11490.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=BAH12374.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=BAH14140.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=CAA04503.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=CAA62629.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=CAG38744.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC       Sequence=EAW97745.1; Type=Erroneous termination; Positions=648; Note=Translated as Sec.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/txnrd1/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X91247; CAA62629.1; ALT_SEQ; mRNA.
DR   EMBL; S79851; AAB35418.1; ALT_SEQ; mRNA.
DR   EMBL; D88687; BAA13674.1; ALT_SEQ; mRNA.
DR   EMBL; AF077367; AAC69621.1; ALT_SEQ; mRNA.
DR   EMBL; AY057105; AAL15432.1; -; mRNA.
DR   EMBL; AY344081; AAQ62461.1; -; mRNA.
DR   EMBL; AY344083; AAQ62462.1; -; mRNA.
DR   EMBL; AY344084; AAQ62463.1; -; mRNA.
DR   EMBL; AY344086; AAQ62464.1; -; mRNA.
DR   EMBL; AY344087; AAQ62465.1; -; mRNA.
DR   EMBL; AY344089; AAQ62466.1; -; mRNA.
DR   EMBL; AY344092; AAQ62467.1; -; mRNA.
DR   EMBL; AY344093; AAQ62468.1; -; mRNA.
DR   EMBL; AY344095; AAQ62469.1; -; mRNA.
DR   EMBL; AY344096; AAQ62470.1; -; mRNA.
DR   EMBL; AY344670; AAQ62471.1; -; mRNA.
DR   EMBL; AY344673; AAQ62472.1; -; mRNA.
DR   EMBL; AY344679; AAQ62473.1; -; mRNA.
DR   EMBL; AJ001050; CAA04503.1; ALT_SEQ; mRNA.
DR   EMBL; AF208018; AAF15900.1; ALT_SEQ; mRNA.
DR   EMBL; AK293322; BAH11490.1; ALT_SEQ; mRNA.
DR   EMBL; AK296495; BAH12374.1; ALT_SEQ; mRNA.
DR   EMBL; AK304241; BAH14140.1; ALT_SEQ; mRNA.
DR   EMBL; CR536506; CAG38744.1; ALT_SEQ; mRNA.
DR   EMBL; BT019640; AAV38446.1; ALT_SEQ; mRNA.
DR   EMBL; DQ157758; AAZ67916.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AC089983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090107; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471054; EAW97745.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC018122; AAH18122.2; -; mRNA.
DR   CCDS; CCDS53820.1; -. [Q16881-1]
DR   CCDS; CCDS53821.1; -. [Q16881-4]
DR   CCDS; CCDS53823.1; -. [Q16881-5]
DR   CCDS; CCDS58274.1; -. [Q16881-7]
DR   PIR; S66677; S66677.
DR   RefSeq; NP_001087240.1; NM_001093771.2. [Q16881-1]
DR   RefSeq; NP_001248374.1; NM_001261445.1.
DR   RefSeq; NP_001248375.1; NM_001261446.1. [Q16881-7]
DR   RefSeq; NP_003321.3; NM_003330.3. [Q16881-4]
DR   RefSeq; NP_877393.1; NM_182729.2. [Q16881-5]
DR   RefSeq; NP_877419.1; NM_182742.2. [Q16881-5]
DR   RefSeq; NP_877420.1; NM_182743.2. [Q16881-5]
DR   UniGene; Hs.654922; -.
DR   UniGene; Hs.690011; -.
DR   PDB; 1W1C; Model; -; A/B=161-649.
DR   PDB; 2CFY; X-ray; 2.70 A; A/B/C/D/E/F=151-647.
DR   PDB; 2J3N; X-ray; 2.80 A; A/B/C/D/E/F=151-647.
DR   PDB; 2ZZ0; X-ray; 2.80 A; A/B/C/D=150-647.
DR   PDB; 2ZZB; X-ray; 3.20 A; A/B/C/D=150-647.
DR   PDB; 2ZZC; X-ray; 2.60 A; A/B/C/D=150-647.
DR   PDB; 3QFA; X-ray; 2.20 A; A/B=151-649.
DR   PDB; 3QFB; X-ray; 2.60 A; A/B=151-649.
DR   PDBsum; 1W1C; -.
DR   PDBsum; 2CFY; -.
DR   PDBsum; 2J3N; -.
DR   PDBsum; 2ZZ0; -.
DR   PDBsum; 2ZZB; -.
DR   PDBsum; 2ZZC; -.
DR   PDBsum; 3QFA; -.
DR   PDBsum; 3QFB; -.
DR   ProteinModelPortal; Q16881; -.
DR   SMR; Q16881; -.
DR   BioGrid; 113147; 39.
DR   IntAct; Q16881; 9.
DR   MINT; MINT-1525880; -.
DR   STRING; 9606.ENSP00000434516; -.
DR   BindingDB; Q16881; -.
DR   ChEMBL; CHEMBL1927; -.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   DrugBank; DB03147; Flavin adenine dinucleotide.
DR   DrugBank; DB04106; Fotemustine.
DR   DrugBank; DB05428; motexafin gadolinium.
DR   DrugBank; DB02338; Nadph Dihydro-Nicotinamide-Adenine-Dinucleotidephosphate.
DR   DrugBank; DB05448; PX-12.
DR   DrugBank; DB03566; Spermidine.
DR   iPTMnet; Q16881; -.
DR   PhosphoSitePlus; Q16881; -.
DR   SwissPalm; Q16881; -.
DR   BioMuta; TXNRD1; -.
DR   DMDM; 172046253; -.
DR   REPRODUCTION-2DPAGE; IPI00554786; -.
DR   EPD; Q16881; -.
DR   MaxQB; Q16881; -.
DR   PaxDb; Q16881; -.
DR   PeptideAtlas; Q16881; -.
DR   PRIDE; Q16881; -.
DR   DNASU; 7296; -.
DR   Ensembl; ENST00000503506; ENSP00000421934; ENSG00000198431. [Q16881-5]
DR   Ensembl; ENST00000524698; ENSP00000433425; ENSG00000198431. [Q16881-5]
DR   Ensembl; ENST00000525566; ENSP00000434516; ENSG00000198431. [Q16881-1]
DR   Ensembl; ENST00000526390; ENSP00000435123; ENSG00000198431. [Q16881-2]
DR   Ensembl; ENST00000526691; ENSP00000435929; ENSG00000198431. [Q16881-4]
DR   Ensembl; ENST00000529546; ENSP00000434919; ENSG00000198431. [Q16881-7]
DR   GeneID; 7296; -.
DR   KEGG; hsa:7296; -.
DR   UCSC; uc010swp.4; human. [Q16881-1]
DR   CTD; 7296; -.
DR   DisGeNET; 7296; -.
DR   GeneCards; TXNRD1; -.
DR   H-InvDB; HIX0010939; -.
DR   HGNC; HGNC:12437; TXNRD1.
DR   HPA; CAB004607; -.
DR   HPA; CAB015834; -.
DR   HPA; HPA001395; -.
DR   HPA; HPA043871; -.
DR   MIM; 601112; gene.
DR   neXtProt; NX_Q16881; -.
DR   OpenTargets; ENSG00000198431; -.
DR   PharmGKB; PA37093; -.
DR   eggNOG; KOG1752; Eukaryota.
DR   eggNOG; KOG4716; Eukaryota.
DR   eggNOG; COG1249; LUCA.
DR   GeneTree; ENSGT00390000007578; -.
DR   HOVERGEN; HBG004959; -.
DR   InParanoid; Q16881; -.
DR   KO; K00384; -.
DR   OrthoDB; EOG091G03IU; -.
DR   PhylomeDB; Q16881; -.
DR   TreeFam; TF314782; -.
DR   BRENDA; 1.8.1.9; 2681.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-2408550; Metabolism of ingested H2SeO4 and H2SeO3 into H2Se.
DR   Reactome; R-HSA-3299685; Detoxification of Reactive Oxygen Species.
DR   Reactome; R-HSA-499943; Synthesis and interconversion of nucleotide di- and triphosphates.
DR   Reactome; R-HSA-5263617; Metabolism of ingested MeSeO2H into MeSeH.
DR   Reactome; R-HSA-5336415; Uptake and function of diphtheria toxin.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   ChiTaRS; TXNRD1; human.
DR   EvolutionaryTrace; Q16881; -.
DR   GeneWiki; TXNRD1; -.
DR   GenomeRNAi; 7296; -.
DR   PRO; PR:Q16881; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000198431; -.
DR   ExpressionAtlas; Q16881; baseline and differential.
DR   Genevisible; Q16881; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0009055; F:electron carrier activity; IEA:InterPro.
DR   GO; GO:0050660; F:flavin adenine dinucleotide binding; IEA:InterPro.
DR   GO; GO:0098626; F:methylseleninic acid reductase activity; TAS:Reactome.
DR   GO; GO:0098625; F:methylselenol reductase activity; TAS:Reactome.
DR   GO; GO:0015035; F:protein disulfide oxidoreductase activity; IEA:InterPro.
DR   GO; GO:0004791; F:thioredoxin-disulfide reductase activity; EXP:Reactome.
DR   GO; GO:0045454; P:cell redox homeostasis; IBA:GO_Central.
DR   GO; GO:0015949; P:nucleobase-containing small molecule interconversion; TAS:Reactome.
DR   GO; GO:0000305; P:response to oxygen radical; IBA:GO_Central.
DR   GO; GO:0000302; P:response to reactive oxygen species; TAS:Reactome.
DR   GO; GO:0001887; P:selenium compound metabolic process; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   Gene3D; 3.30.390.30; -; 1.
DR   Gene3D; 3.50.50.60; -; 1.
DR   InterPro; IPR023753; FAD/NAD-binding_dom.
DR   InterPro; IPR016156; FAD/NAD-linked_Rdtase_dimer.
DR   InterPro; IPR002109; Glutaredoxin.
DR   InterPro; IPR004099; Pyr_nucl-diS_OxRdtase_dimer.
DR   InterPro; IPR012999; Pyr_OxRdtase_I_AS.
DR   InterPro; IPR012336; Thioredoxin-like_fold.
DR   InterPro; IPR006338; Thioredoxin/glutathione_Rdtase.
DR   Pfam; PF00462; Glutaredoxin; 1.
DR   Pfam; PF07992; Pyr_redox_2; 1.
DR   Pfam; PF02852; Pyr_redox_dim; 1.
DR   SUPFAM; SSF51905; SSF51905; 1.
DR   SUPFAM; SSF52833; SSF52833; 1.
DR   SUPFAM; SSF55424; SSF55424; 1.
DR   TIGRFAMs; TIGR01438; TGR; 1.
DR   PROSITE; PS51354; GLUTAREDOXIN_2; 1.
DR   PROSITE; PS00076; PYRIDINE_REDOX_1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Disulfide bond;
KW   Electron transport; FAD; Flavoprotein; NADP; Nucleus; Oxidoreductase;
KW   Phosphoprotein; Polymorphism; Redox-active center; Reference proteome;
KW   Selenocysteine; Transport; Ubl conjugation.
FT   CHAIN         1    649       Thioredoxin reductase 1, cytoplasmic.
FT                                /FTId=PRO_0000030286.
FT   DOMAIN       56    156       Glutaredoxin. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00686}.
FT   NP_BIND     192    209       FAD. {ECO:0000250}.
FT   ACT_SITE    622    622       Proton acceptor. {ECO:0000250}.
FT   NON_STD     648    648       Selenocysteine.
FT                                {ECO:0000269|PubMed:8650234}.
FT   MOD_RES     218    218       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:Q9JMH6}.
FT   MOD_RES     281    281       Phosphotyrosine.
FT                                {ECO:0000244|PubMed:15592455}.
FT   DISULFID    209    214       Redox-active. {ECO:0000250}.
FT   CROSSLNK    647    648       Cysteinyl-selenocysteine (Cys-Sec).
FT                                {ECO:0000250}.
FT   VAR_SEQ       1    188       Missing (in isoform 7).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_053819.
FT   VAR_SEQ       1    150       Missing (in isoform 5).
FT                                {ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:7589432,
FT                                ECO:0000303|PubMed:9774665,
FT                                ECO:0000303|Ref.5, ECO:0000303|Ref.6,
FT                                ECO:0000303|Ref.8, ECO:0000303|Ref.9}.
FT                                /FTId=VSP_031558.
FT   VAR_SEQ       1    139       MGCAEGKAVAAAAPTELQTKGKNGDGRRRSAKDHHPGKTLP
FT                                ENPAGFTSTATADSRALLQAYIDGHSVVIFSRSTCTRCTEV
FT                                KKLFKSLCVPYFVLELDQTEDGRALEGTLSELAAETDLPVV
FT                                FVKQRKIGGHGPTLKA -> MPVDDYWLCLPASCARPFVQT
FT                                VRVVQSCPHCCWFPGVLPSVPEPLRMPAMLPTGSHSAVLPP
FT                                SHCSTAPPSTSQEPSSSADPKLCLSPPTSDSRQERNVQFGL
FT                                A (in isoform 6). {ECO:0000305}.
FT                                /FTId=VSP_031559.
FT   VAR_SEQ       1    106       Missing (in isoform 2). {ECO:0000305}.
FT                                /FTId=VSP_031560.
FT   VAR_SEQ       1     98       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:8999974}.
FT                                /FTId=VSP_031561.
FT   VAR_SEQ       1     51       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_031562.
FT   VAR_SEQ      52    100       TADSRALLQAYIDGHSVVIFSRSTCTRCTEVKKLFKSLCVP
FT                                YFVLELDQ -> MQQVMLTCKGVNRGHAVPAGPGRKPRPRR
FT                                SSRLLAGEKHLTRSALLLCH (in isoform 3).
FT                                {ECO:0000305}.
FT                                /FTId=VSP_031563.
FT   VAR_SEQ      99    101       DQT -> MSC (in isoform 4).
FT                                {ECO:0000303|PubMed:8999974}.
FT                                /FTId=VSP_031564.
FT   VAR_SEQ     107    138       LEGTLSELAAETDLPVVFVKQRKIGGHGPTLK -> MLSRL
FT                                VLNSWAQAIIRPRPPKVLGLQVTTFSE (in isoform
FT                                2). {ECO:0000305}.
FT                                /FTId=VSP_031565.
FT   VARIANT     365    365       D -> G (in dbSNP:rs1127954).
FT                                {ECO:0000269|PubMed:14980707,
FT                                ECO:0000269|PubMed:7589432}.
FT                                /FTId=VAR_051776.
FT   CONFLICT    153    153       G -> S (in Ref. 4; AAQ62473).
FT                                {ECO:0000305}.
FT   CONFLICT    181    181       A -> P (in Ref. 6; AAF15900).
FT                                {ECO:0000305}.
FT   CONFLICT    194    194       V -> G (in Ref. 6; AAF15900).
FT                                {ECO:0000305}.
FT   CONFLICT    200    200       G -> E (in Ref. 4; AAQ62469).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       R -> K (in Ref. 4; AAQ62463).
FT                                {ECO:0000305}.
FT   CONFLICT    215    215       I -> N (in Ref. 4; AAQ62463).
FT                                {ECO:0000305}.
FT   CONFLICT    297    297       G -> D (in Ref. 7; BAH11490).
FT                                {ECO:0000305}.
FT   CONFLICT    306    306       R -> S (in Ref. 1; AAB35418/CAA62629 and
FT                                4; AAL15432). {ECO:0000305}.
FT   CONFLICT    365    365       D -> N (in Ref. 3; AAC69621).
FT                                {ECO:0000305}.
FT   CONFLICT    437    437       V -> A (in Ref. 7; BAH12374).
FT                                {ECO:0000305}.
FT   CONFLICT    441    441       I -> M (in Ref. 7; BAH12374).
FT                                {ECO:0000305}.
FT   CONFLICT    449    449       K -> R (in Ref. 8; CAG38744).
FT                                {ECO:0000305}.
FT   CONFLICT    641    641       S -> R (in Ref. 3; AAC69621).
FT                                {ECO:0000305}.
FT   STRAND      162    168       {ECO:0000244|PDB:3QFA}.
FT   HELIX       172    183       {ECO:0000244|PDB:3QFA}.
FT   STRAND      188    191       {ECO:0000244|PDB:3QFA}.
FT   HELIX       208    212       {ECO:0000244|PDB:3QFA}.
FT   HELIX       214    233       {ECO:0000244|PDB:3QFA}.
FT   TURN        234    237       {ECO:0000244|PDB:3QFA}.
FT   HELIX       248    272       {ECO:0000244|PDB:3QFA}.
FT   STRAND      276    278       {ECO:0000244|PDB:3QFA}.
FT   STRAND      280    286       {ECO:0000244|PDB:3QFA}.
FT   STRAND      289    293       {ECO:0000244|PDB:3QFA}.
FT   STRAND      295    297       {ECO:0000244|PDB:2ZZ0}.
FT   STRAND      301    309       {ECO:0000244|PDB:3QFA}.
FT   STRAND      313    315       {ECO:0000244|PDB:3QFA}.
FT   HELIX       323    326       {ECO:0000244|PDB:3QFA}.
FT   HELIX       330    333       {ECO:0000244|PDB:3QFA}.
FT   STRAND      342    346       {ECO:0000244|PDB:3QFA}.
FT   HELIX       350    361       {ECO:0000244|PDB:3QFA}.
FT   STRAND      366    372       {ECO:0000244|PDB:3QFA}.
FT   TURN        374    377       {ECO:0000244|PDB:2ZZ0}.
FT   HELIX       380    392       {ECO:0000244|PDB:3QFA}.
FT   STRAND      396    410       {ECO:0000244|PDB:3QFA}.
FT   STRAND      412    414       {ECO:0000244|PDB:2J3N}.
FT   STRAND      416    427       {ECO:0000244|PDB:3QFA}.
FT   STRAND      429    439       {ECO:0000244|PDB:3QFA}.
FT   STRAND      443    446       {ECO:0000244|PDB:3QFA}.
FT   STRAND      448    450       {ECO:0000244|PDB:3QFA}.
FT   TURN        453    456       {ECO:0000244|PDB:3QFA}.
FT   TURN        461    463       {ECO:0000244|PDB:3QFA}.
FT   STRAND      479    481       {ECO:0000244|PDB:3QFA}.
FT   HELIX       483    485       {ECO:0000244|PDB:3QFA}.
FT   STRAND      486    489       {ECO:0000244|PDB:3QFA}.
FT   HELIX       493    508       {ECO:0000244|PDB:3QFA}.
FT   STRAND      522    524       {ECO:0000244|PDB:3QFA}.
FT   STRAND      526    528       {ECO:0000244|PDB:3QFA}.
FT   STRAND      530    534       {ECO:0000244|PDB:3QFA}.
FT   HELIX       537    544       {ECO:0000244|PDB:3QFA}.
FT   HELIX       546    548       {ECO:0000244|PDB:3QFA}.
FT   STRAND      549    556       {ECO:0000244|PDB:3QFA}.
FT   HELIX       559    562       {ECO:0000244|PDB:3QFA}.
FT   TURN        563    565       {ECO:0000244|PDB:3QFA}.
FT   TURN        568    570       {ECO:0000244|PDB:3QFA}.
FT   STRAND      571    578       {ECO:0000244|PDB:3QFA}.
FT   TURN        579    582       {ECO:0000244|PDB:3QFA}.
FT   STRAND      584    592       {ECO:0000244|PDB:3QFA}.
FT   HELIX       595    607       {ECO:0000244|PDB:3QFA}.
FT   HELIX       612    617       {ECO:0000244|PDB:3QFA}.
FT   HELIX       625    631       {ECO:0000244|PDB:3QFA}.
FT   TURN        636    639       {ECO:0000244|PDB:3QFA}.
SQ   SEQUENCE   649 AA;  70906 MW;  5A51C3F77EB03EFE CRC64;
     MGCAEGKAVA AAAPTELQTK GKNGDGRRRS AKDHHPGKTL PENPAGFTST ATADSRALLQ
     AYIDGHSVVI FSRSTCTRCT EVKKLFKSLC VPYFVLELDQ TEDGRALEGT LSELAAETDL
     PVVFVKQRKI GGHGPTLKAY QEGRLQKLLK MNGPEDLPKS YDYDLIIIGG GSGGLAAAKE
     AAQYGKKVMV LDFVTPTPLG TRWGLGGTCV NVGCIPKKLM HQAALLGQAL QDSRNYGWKV
     EETVKHDWDR MIEAVQNHIG SLNWGYRVAL REKKVVYENA YGQFIGPHRI KATNNKGKEK
     IYSAERFLIA TGERPRYLGI PGDKEYCISS DDLFSLPYCP GKTLVVGASY VALECAGFLA
     GIGLDVTVMV RSILLRGFDQ DMANKIGEHM EEHGIKFIRQ FVPIKVEQIE AGTPGRLRVV
     AQSTNSEEII EGEYNTVMLA IGRDACTRKI GLETVGVKIN EKTGKIPVTD EEQTNVPYIY
     AIGDILEDKV ELTPVAIQAG RLLAQRLYAG STVKCDYENV PTTVFTPLEY GACGLSEEKA
     VEKFGEENIE VYHSYFWPLE WTIPSRDNNK CYAKIICNTK DNERVVGFHV LGPNAGEVTQ
     GFAAALKCGL TKKQLDSTIG IHPVCAEVFT TLSVTKRSGA SILQAGCUG
//
